Immune checkpoint inhibitors have promising clinical activity across multiple gastrointestinal cancers and immune-mediated hepatotoxicity is particularly relevant for this group of patients. In this article we will review the recognition, workup and management of suspected checkpoint inhibitor related immune-hepatitis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848041 | PMC |
| http://dx.doi.org/10.21037/jgo.2017.08.14 | DOI Listing |
Publication Analysis
Top Keywords
approach management
4
management checkpoint
4
checkpoint inhibitor-related
4
inhibitor-related immune
4
immune hepatitis
4
hepatitis immune
4
immune checkpoint
4
checkpoint inhibitors
4
inhibitors promising
4
promising clinical
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!